148.60
+2.00
+(1.36%)
At close: April 16 at 4:59:53 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | 4 | 4 |
Avg. Estimate | 0 | 0 | 5.28 | 6.11 |
Low Estimate | 0 | 0 | 5.13 | 5.89 |
High Estimate | 0 | 0 | 5.54 | 6.48 |
Year Ago EPS | -- | 0.9 | 3.7 | 5.28 |
Revenue Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | 4 | 4 |
Avg. Estimate | -- | -- | 6.2B | 7.01B |
Low Estimate | -- | -- | 6.18B | 6.92B |
High Estimate | -- | -- | 6.22B | 7.17B |
Year Ago Sales | -- | -- | 5.54B | 6.2B |
Sales Growth (year/est) | -- | -- | 12.02% | 13.08% |
Earnings History
Currency in DKK | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | 0.96 | 0.75 | 0.79 | 0.95 |
EPS Actual | 1.1 | 0.9 | 1 | 0.8 |
Difference | 0.14 | 0.15 | 0.21 | -0.15 |
Surprise % | 13.99% | 20.00% | 26.58% | -15.79% |
EPS Trend
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 5.28 | 6.11 |
7 Days Ago | 0 | 0 | 5.32 | 6.15 |
30 Days Ago | 0 | 0 | 5.32 | 6.15 |
60 Days Ago | 0 | 0 | 5.39 | 6.33 |
90 Days Ago | 0 | 0 | 5.42 | 6.25 |
EPS Revisions
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | 1 | 1 |
Down Last 30 Days | -- | -- | 2 | 2 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ALK-B.CO | -- | -- | 42.77% | 15.62% |
S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Related Tickers
BAVA.CO Bavarian Nordic A/S
151.65
+0.43%
GMAB.CO Genmab A/S
1,291.50
-0.12%
ZEAL.CO Zealand Pharma A/S
424.50
-4.61%
GUBRA.CO Gubra A/S
356.00
-4.30%
FLUO.ST FluoGuide A/S
38.00
-2.56%
SANION.ST Saniona AB (publ)
6.40
+4.07%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
18.98
-2.16%
GMAB Genmab A/S
20.04
+2.51%
CAMX.ST Camurus AB (publ)
566.00
+0.62%
96X.F FluoGuide A/S
3.1700
0.00%